Jaime Imitola - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
Neural stem cells and Neuroimmunology

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Watanabe F, Hollingsworth EW, Bartley JM, Wisehart L, Desai R, Hartlaub AM, Hester ME, Schiapparelli P, Quiñones-Hinojosa A, Imitola J. Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma. Pnas Nexus. 3: pgae051. PMID 38384384 DOI: 10.1093/pnasnexus/pgae051  0.785
2023 Imitola J, Hollingsworth EW, Watanabe F, Olah M, Elyaman W, Starossom S, Kivisäkk P, Khoury SJ. is an inducible transcriptional repressor of neural stem cells self-renewal program during neuroinflammation. Frontiers in Cellular Neuroscience. 17: 1156802. PMID 37663126 DOI: 10.3389/fncel.2023.1156802  0.774
2023 Leung CS, Rosenzweig S, Yoon B, Marinelli NA, Hollingsworth EW, Maguire AM, Cowen MH, Schmidt M, Imitola J, Gamsiz Uzun ED, Lizarraga SB. Dysregulation of the chromatin environment leads to differential alternative splicing as a mechanism of disease in a human model of autism spectrum disorder. Human Molecular Genetics. PMID 36621967 DOI: 10.1093/hmg/ddad002  0.749
2023 Suarez-Meade P, Watanabe F, Ruiz-Garcia H, Rafferty SB, Moniz-Garcia D, Schiapparelli PV, Jentoft ME, Imitola J, Quinones-Hinojosa A. SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models. Journal of Neuro-Oncology. 1-10. PMID 36595192 DOI: 10.1007/s11060-022-04205-2  0.77
2022 Ruiz-Garcia H, Zarco N, Watanabe F, De Araujo Farias V, Suarez-Meade P, Guerrero-Cazares H, Imitola J, Quinones-Hinojosa A, Trifiletti D. Development of Experimental Three-Dimensional Tumor Models to Study Glioblastoma Cancer Stem Cells and Tumor Microenvironment. Methods in Molecular Biology (Clifton, N.J.). 2572: 117-127. PMID 36161412 DOI: 10.1007/978-1-0716-2703-7_9  0.759
2021 Watanabe F, Schoeffler A, Fair SR, Hester ME, Fedorko J, Imitola J. Generation of Neurosphere-Derived Organoid-Like-Aggregates (NEDAS) from Neural Stem Cells. Current Protocols. 1: e15. PMID 33534198 DOI: 10.1002/cpz1.15  0.786
2020 Fair SR, Julian D, Hartlaub AM, Pusuluri ST, Malik G, Summerfied TL, Zhao G, Hester AB, Ackerman WE, Hollingsworth EW, Ali M, McElroy CA, Buhimschi IA, Imitola J, Maitre NL, et al. Electrophysiological Maturation of Cerebral Organoids Correlates with Dynamic Morphological and Cellular Development. Stem Cell Reports. PMID 32976764 DOI: 10.1016/j.stemcr.2020.08.017  0.743
2020 Al-Kharboosh R, ReFaey K, Lara-Velazquez M, Grewal SS, Imitola J, Quiñones-Hinojosa A. Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 4: 443-459. PMID 32793872 DOI: 10.1016/J.Mayocpiqo.2020.04.006  0.355
2020 Julian K, Yuhasz N, Rai W, Salerno JA, Imitola J. Complications from "Stem Cell Tourism" in Neurology. Annals of Neurology. PMID 32632977 DOI: 10.1002/ana.25842  0.653
2019 Mengesha T, Squires N, Oas J, Imitola J. A possible link between intracranial lipomas and localization-related relapses in multiple sclerosis. Multiple Sclerosis and Related Disorders. 38: 101502. PMID 31715501 DOI: 10.1016/j.msard.2019.101502  0.304
2019 Julian D, Hollingsworth EW, Julian K, Imitola J. Convergence of human cellular models and genetics to study neural stem cell signaling to enhance central nervous system regeneration and repair. Seminars in Cell & Developmental Biology. PMID 31310810 DOI: 10.1016/J.Semcdb.2019.07.002  0.774
2019 Imitola J. Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repair. Journal of Neuroimmunology. PMID 31023492 DOI: 10.1016/j.jneuroim.2019.04.008  0.446
2019 Imitola J. New age for progressive multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 116: 8646-8648. PMID 31004053 DOI: 10.1073/pnas.1903796116  0.382
2019 Starossom SC, Campo Garcia J, Woelfle T, Romero-Suarez S, Olah M, Watanabe F, Cao L, Yeste A, Tukker JJ, Quintana FJ, Imitola J, Witzel F, Schmitz D, Morkel M, Paul F, et al. Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation. Nature Communications. 10: 217. PMID 30644388 DOI: 10.1038/S41467-018-08140-7  0.806
2018 Julian K, Yuhasz N, Hollingsworth E, Imitola J. The "Growing" Reality of the Neurological Complications of Global "Stem Cell Tourism". Seminars in Neurology. 38: 176-181. PMID 29791943 DOI: 10.1055/S-0038-1649338  0.812
2018 Alldredge B, Jordan A, Imitola J, Racke MK. Safety and Efficacy of Rituximab: Experience of a Single Multiple Sclerosis Center. Clinical Neuropharmacology. PMID 29389745 DOI: 10.1097/WNF.0000000000000268  0.335
2017 Imitola J, Rasouli J, Watanabe F, Mahajan K, Sharan AD, Ciric B, Zhang GX, Rostami A. Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions. Journal of Neuroimmunology. PMID 29290406 DOI: 10.1016/J.Jneuroim.2017.12.017  0.783
2017 Ryan KJ, White CC, Patel K, Xu J, Olah M, Replogle JM, Frangieh M, Cimpean M, Winn P, McHenry A, Kaskow BJ, Chan G, Cuerdon N, Bennett DA, Boyd JD, ... Imitola J, et al. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Science Translational Medicine. 9. PMID 29263232 DOI: 10.1126/Scitranslmed.Aai7635  0.417
2017 Banasavadi-Siddegowda YK, Welker AM, An M, Yang X, Zhou W, Shi G, Imitola J, Li C, Hsu S, Wang J, Phelps M, Zhang J, Beattie CE, Baiocchi R, Kaur B. PRMT5 as a druggable target for glioblastoma therapy. Neuro-Oncology. PMID 29106602 DOI: 10.1093/Neuonc/Nox206  0.404
2017 Hollingsworth EW, Vaughn JE, Orack JC, Skinner C, Khouri J, Lizarraga SB, Hester ME, Watanabe F, Kosik KS, Imitola J. iPhemap: an atlas of phenotype to genotype relationships of human iPSC models of neurological diseases. Embo Molecular Medicine. PMID 29051230 DOI: 10.15252/Emmm.201708191  0.782
2017 Racke MK, Imitola J. Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell Transplantation. Jama Neurology. PMID 28241157 DOI: 10.1001/jamaneurol.2016.5925  0.405
2017 Del Sol A, Thiesen HJ, Imitola J, Salas RE. Big-Data-Driven Stem Cell Science and Tissue Engineering: Vision and Unique Opportunities. Cell Stem Cell. 20: 157-160. PMID 28157497 DOI: 10.1016/j.stem.2017.01.006  0.447
2017 Hollingsworth E, Khouri J, Imitola J. Endogenous repair and development inspired therapy of neurodegeneration in progressive multiple sclerosis. Expert Review of Neurotherapeutics. PMID 28128996 DOI: 10.1080/14737175.2017.1287564  0.802
2016 Banasavadi-Siddegowda YK, Russell L, Frair E, Karkhanis VA, Relation T, Yoo JY, Zhang J, Sif S, Imitola J, Baiocchi R, Kaur B. PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells. Oncogene. PMID 27292259 DOI: 10.1038/Onc.2016.199  0.447
2016 Grewal J, Dalal P, Bowman M, Kaya B, Otero JJ, Imitola J. Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression. Journal of Neurovirology. PMID 27273076 DOI: 10.1007/S13365-016-0459-Y  0.348
2016 Banasavadi-Siddegowda YK, Russell L, Zhang J, Karkhanis VA, Imitola J, Baiocchi R, Kaur B. Abstract 2845: PRMT5-PTEN molecular pathway regulates senescence and self-renewal of Glioblastoma stem-like cells Cancer Research. 76: 2845-2845. DOI: 10.1158/1538-7445.Am2016-2845  0.481
2015 Welker AM, Jaros BD, Puduvalli VK, Imitola J, Kaur B, Beattie CE. Standardized orthotopic xenografts in zebrafish reveal glioma cell line specific characteristics and tumor cell heterogeneity. Disease Models & Mechanisms. PMID 26659251 DOI: 10.1242/Dmm.022921  0.425
2015 Bowman M, Racke M, Kissel J, Imitola J. Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor. Jama Neurology. 72: 1342-5. PMID 26322563 DOI: 10.1001/jamaneurol.2015.1891  0.423
2015 Imitola J, Khurana DS, Teplyuk NM, Zucker M, Jethva R, Legido A, Krichevsky AM, Frangieh M, Walsh CA, Carvalho KS. A novel 2q37 microdeletion containing human neural progenitors genes including STK25 results in severe developmental delay, epilepsy, and microcephaly. American Journal of Medical Genetics. Part A. PMID 26238961 DOI: 10.1002/ajmg.a.37268  0.301
2015 Merzaban JS, Imitola J, Starossom SC, Zhu B, Wang Y, Lee J, Ali AJ, Olah M, Abuelela AF, Khoury SJ, Sackstein R. Cell Surface Glycan Engineering of Neural Stem Cells Augments Neurotropism and Improves Recovery in a Murine Model of Multiple Sclerosis. Glycobiology. PMID 26153105 DOI: 10.1093/glycob/cwv046  0.812
2015 Imitola J, Wagoner J, Khurana JS. Rapid dissemination of granular cell astrocytoma arising from periventricular stem cell regions in chronic multiple sclerosis. Journal of Neuro-Oncology. 124: 147-9. PMID 26003876 DOI: 10.1007/s11060-015-1811-4  0.468
2015 Rasouli J, Ciric B, Imitola J, Gonnella P, Hwang D, Mahajan K, Mari ER, Safavi F, Leist TP, Zhang GX, Rostami A. Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy. Journal of Immunology (Baltimore, Md. : 1950). 194: 5085-93. PMID 25917097 DOI: 10.4049/jimmunol.1403243  0.358
2015 Orack JC, Deleidi M, Pitt D, Mahajan K, Nicholas JA, Boster AL, Racke MK, Comabella M, Watanabe F, Imitola J. Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration. Stem Cells Translational Medicine. 4: 252-60. PMID 25593207 DOI: 10.5966/Sctm.2014-0133  0.83
2015 Imitola J, Racke MK. Is no evidence of disease activity a realistic goal for patients with multiple sclerosis? Jama Neurology. 72: 145-7. PMID 25531742 DOI: 10.1001/jamaneurol.2014.3860  0.339
2015 Durvasula S, Imitola J. The cerebrospinal fluid-stem cell interactions as target for regenerative therapy in neurological diseases. Stem Cells and Development. 24: 145-6. PMID 25517016 DOI: 10.1089/scd.2014.0572  0.419
2014 Nicholas JA, Boster AL, Imitola J, O'Connell C, Racke MK. Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate. Drug Design, Development and Therapy. 8: 897-908. PMID 25045248 DOI: 10.2147/DDDT.S50962  0.331
2014 Banasavadi-Siddegowda YK, Imitola J, Baiocchi R, Kaur B. RM-01 * RADIATION INDUCED PRMT5 EXPRESSION IS REGULATED BY miRNA-96 IN GLIOBLASTOMA Neuro-Oncology. 16: v186-v186. DOI: 10.1093/Neuonc/Nou273.1  0.306
2014 Ryan K, Chan G, Olah M, Winn P, Cimpean M, Frangieh M, Imitola J, Elyaman W, De Jager P, Bradshaw E. Utilizing an in vitro microglia-like model for exploring genetic-driven innate immune system dysfunction in Alzheimer's disease Journal of Neuroimmunology. 275: 82. DOI: 10.1016/j.jneuroim.2014.08.217  0.311
2013 Gonzalez R, Teng YD, Park KI, Lee JP, Ourednik J, Ourednik V, Imitola J, Mueller FJ, Sidman RL, Snyder EY. Neural Stem Cells - Therapeutic Applications in Neurodegenerative Diseases Essentials of Stem Cell Biology: Third Edition. 467-489. DOI: 10.1016/B978-0-12-409503-8.00032-9  0.709
2013 Gonzalez R, Teng YD, Park KI, Lee JP, Ourednik J, Ourednik V, Imitola J, Mueller FJ, Sidman RL, Snyder EY. Neural Stem Cells-Therapeutic Applications in Neurodegenerative Diseases Handbook of Stem Cells. 2: 707-721. DOI: 10.1016/B978-0-12-385942-6.00061-5  0.709
2012 Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity. 37: 249-63. PMID 22884314 DOI: 10.1016/j.immuni.2012.05.023  0.775
2012 Imitola J, Pitt K, Peoples JL, Krynska B, Sheikh H, Kesari S, Azizi SA. Multifocal CNS infiltration of chronic lymphocytic leukemia in the form of small-cell solid metastatic lesions. Journal of Neuro-Oncology. 109: 213-5. PMID 22573347 DOI: 10.1007/S11060-012-0869-5  0.311
2011 Rasmussen S, Imitola J, Ayuso-Sacido A, Wang Y, Starossom SC, Kivisäkk P, Zhu B, Meyer M, Bronson RT, Garcia-Verdugo JM, Khoury SJ. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Annals of Neurology. 69: 878-91. PMID 21391234 DOI: 10.1002/Ana.22299  0.826
2011 Imitola J, Côté D, Rasmussen S, Xie XS, Liu Y, Chitnis T, Sidman RL, Lin CP, Khoury SJ. Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice. Journal of Biomedical Optics. 16: 021109. PMID 21361672 DOI: 10.1117/1.3533312  0.623
2011 Starossom SC, Imitola J, Wang Y, Cao L, Khoury SJ. Subventricular zone microglia transcriptional networks. Brain, Behavior, and Immunity. 25: 991-9. PMID 21074605 DOI: 10.1016/j.bbi.2010.11.002  0.78
2009 Kivisäkk P, Imitola J, Rasmussen S, Elyaman W, Zhu B, Ransohoff RM, Khoury SJ. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Annals of Neurology. 65: 457-69. PMID 18496841 DOI: 10.1002/Ana.21379  0.515
2009 Starossom S, Imitola J, Raddassi K, Elyaman W, Rabinovich G, Khoury S. OR.29. Galectin-1 Modulates Microglia Activation and Promotes Regeneration in a Model of Multiple Sclerosis Clinical Immunology. 131: S14-S15. DOI: 10.1016/J.CLIM.2009.03.036  0.345
2008 Wang Y, Imitola J, Rasmussen S, O'Connor KC, Khoury SJ. Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog-Gli1 in autoimmune encephalomyelitis and multiple sclerosis. Annals of Neurology. 64: 417-27. PMID 18991353 DOI: 10.1002/Ana.21457  0.625
2008 Pluchino S, Muzio L, Imitola J, Deleidi M, Alfaro-Cervello C, Salani G, Porcheri C, Brambilla E, Cavasinni F, Bergamaschi A, Garcia-Verdugo JM, Comi G, Khoury SJ, Martino G. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain : a Journal of Neurology. 131: 2564-78. PMID 18757884 DOI: 10.1093/Brain/Awn198  0.494
2008 Elyaman W, Kivisäkk P, Reddy J, Chitnis T, Raddassi K, Imitola J, Bradshaw E, Kuchroo VK, Yagita H, Sayegh MH, Khoury SJ. Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. The American Journal of Pathology. 173: 411-22. PMID 18583313 DOI: 10.2353/Ajpath.2008.080142  0.34
2008 Dietrich J, Imitola J, Kesari S. Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas. Nature Clinical Practice. Oncology. 5: 393-404. PMID 18521117 DOI: 10.1038/Ncponc1132  0.514
2008 Imitola J, Khoury SJ. Neural stem cells and the future treatment of neurological diseases: raising the standard. Methods in Molecular Biology (Clifton, N.J.). 438: 9-16. PMID 18369745 DOI: 10.1007/978-1-59745-133-8_2  0.489
2008 Esposito G, Imitola J, Lu J, De Filippis D, Scuderi C, Ganesh VS, Folkerth R, Hecht J, Shin S, Iuvone T, Chesnut J, Steardo L, Sheen V. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Human Molecular Genetics. 17: 440-57. PMID 17984171 DOI: 10.1093/Hmg/Ddm322  0.354
2008 Wang Y, Zhu B, Elyaman W, Imitola J, Khoury S. F.19. Neural Stem Cells Expand FoxP3+ Treg In Vitro Clinical Immunology. 127: S49. DOI: 10.1016/J.CLIM.2008.03.131  0.415
2007 Imitola J. Prospects for neural stem cell-based therapies for neurological diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 4: 701-14. PMID 17920551 DOI: 10.1016/j.nurt.2007.08.005  0.515
2007 Rasmussen S, Wang Y, Kivisäkk P, Bronson RT, Meyer M, Imitola J, Khoury SJ. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis. Brain : a Journal of Neurology. 130: 2816-29. PMID 17890734 DOI: 10.1093/Brain/Awm219  0.533
2007 Xiao S, Najafian N, Reddy J, Albin M, Zhu C, Jensen E, Imitola J, Korn T, Anderson AC, Zhang Z, Gutierrez C, Moll T, Sobel RA, Umetsu DT, Yagita H, et al. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. The Journal of Experimental Medicine. 204: 1691-702. PMID 17606630 DOI: 10.1084/Jem.20062498  0.302
2007 Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT, Khoury SJ. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. The American Journal of Pathology. 170: 1695-712. PMID 17456775 DOI: 10.2353/Ajpath.2007.060677  0.323
2007 Elyaman W, Kivisakk P, Imitola J, Khoury S, Sayegh M. Differential Gene Expression Identifies Novel Markers of Myelin-Specific Murine Memory CD4+ T Cells Clinical Immunology. 123: S149. DOI: 10.1016/J.CLIM.2007.03.063  0.329
2006 Li J, Imitola J, Snyder EY, Sidman RL. Neural stem cells rescue nervous purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 7839-48. PMID 16870729 DOI: 10.1523/JNEUROSCI.1624-06.2006  0.708
2006 Monsonego A, Imitola J, Petrovic S, Zota V, Nemirovsky A, Baron R, Fisher Y, Owens T, Weiner HL. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 5048-53. PMID 16549802 DOI: 10.1073/Pnas.0506209103  0.467
2006 Imitola J, Chitnis T, Khoury SJ. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Archives of Neurology. 63: 25-33. PMID 16401734 DOI: 10.1001/Archneur.63.1.25  0.425
2006 Rajan P, Park KI, Ourednik V, Lee JP, Imitola J, Mueller FJ, Teng YD, Snyder E. Stem Cell Research and Applications for Human Therapies Drug Discovery Research: New Frontiers in the Post-Genomic Era. 479-506. DOI: 10.1002/9780470131862.ch20  0.552
2005 Mueller FJ, McKercher SR, Imitola J, Loring JF, Yip S, Khoury SJ, Snyder EY. At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo. Ernst Schering Research Foundation Workshop. 83-114. PMID 16315610 DOI: 10.1007/3-540-27626-2_6  0.645
2005 Camelo S, Iglesias AH, Hwang D, Due B, Ryu H, Smith K, Gray SG, Imitola J, Duran G, Assaf B, Langley B, Khoury SJ, Stephanopoulos G, De Girolami U, Ratan RR, et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 164: 10-21. PMID 15885809 DOI: 10.1016/J.Jneuroim.2005.02.022  0.342
2005 Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacology & Therapeutics. 106: 163-77. PMID 15866318 DOI: 10.1016/J.Pharmthera.2004.11.007  0.384
2005 Benou C, Wang Y, Imitola J, VanVlerken L, Chandras C, Karalis KP, Khoury SJ. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 174: 5407-13. PMID 15843539 DOI: 10.4049/Jimmunol.174.9.5407  0.331
2005 Chitnis T, Imitola J, Khoury SJ. Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis. Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 5: 11-26. PMID 15777201 DOI: 10.2174/1568008053174804  0.371
2005 Kutok JL, Yang X, Folkerth RD, Imitola J, Raddassi K, Yano Y, Salahuddin S, Lawitts J, Imboden H, Chinami M, Shirakawa T, Turner H, Khoury S, Sayegh MH, Scadden D, et al. The cell cycle associated protein, HTm4, is expressed in differentiating cells of the hematopoietic and central nervous system in mice. Journal of Molecular Histology. 36: 77-87. PMID 15704002 DOI: 10.1007/S10735-004-3913-8  0.435
2005 Snyder EY, Khoury S, Imitola J. Stem cells attracted by tissue inflammation Cancer Biology and Therapy. 4.  0.564
2004 Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proceedings of the National Academy of Sciences of the United States of America. 101: 18117-22. PMID 15608062 DOI: 10.1073/Pnas.0408258102  0.7
2004 Imitola J, Park KI, Teng YD, Nisim S, Lachyankar M, Ourednik J, Mueller FJ, Yiou R, Atala A, Sidman RL, Tuszynski M, Khoury SJ, Snyder EY. Stem cells: cross-talk and developmental programs. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 359: 823-37. PMID 15293810 DOI: 10.1098/Rstb.2004.1474  0.742
2004 Imitola J, Comabella M, Chandraker AK, Dangond F, Sayegh MH, Snyder EY, Khoury SJ. Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. The American Journal of Pathology. 164: 1615-25. PMID 15111308 DOI: 10.1016/S0002-9440(10)63720-0  0.598
2004 Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, Guerrini R, Walsh CA. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nature Genetics. 36: 69-76. PMID 14647276 DOI: 10.1038/Ng1276  0.39
2004 Gonzalez R, Teng YD, Park KI, Lee JP, Ourednik J, Ourednik V, Imitola J, Mueller FJ, Sidman RL, Snyder EY. Neural Stem Cells: Therapeutic Applications in Neurodegenerative Diseases Handbook of Stem Cells. 1: 687-699. DOI: 10.1016/B978-012436643-5/50077-8  0.709
2003 Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Allport J, Park KI, Teng YD, Lachyankar M, McIntosh T, O'Rourke DM, Khoury S, Weissleder R, Black PM, Weiss W, et al. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer Journal (Sudbury, Mass.). 9: 189-204. PMID 12952304 DOI: 10.1097/00130404-200305000-00007  0.614
2003 Monsonego A, Imitola J, Zota V, Oida T, Weiner HL. Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells. Journal of Immunology (Baltimore, Md. : 1950). 171: 2216-24. PMID 12928365 DOI: 10.4049/Jimmunol.171.5.2216  0.472
2003 Imitola J, Snyder EY, Khoury SJ. Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiological Genomics. 14: 171-97. PMID 12923300 DOI: 10.1152/physiolgenomics.00021.2002  0.677
2002 Kishimoto K, Sandner S, Imitola J, Sho M, Li Y, Langmuir PB, Rothstein DM, Strom TB, Turka LA, Sayegh MH. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. The Journal of Clinical Investigation. 109: 1471-9. PMID 12045261 DOI: 10.1172/Jci14947  0.31
2002 Comabella M, Imitola J, Weiner HL, Khoury SJ. Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients. Journal of Neuroimmunology. 126: 205-12. PMID 12020972 DOI: 10.1016/S0165-5728(02)00064-4  0.448
2001 Makhlouf K, Comabella M, Imitola J, Weiner HL, Khoury SJ. Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis. Journal of Neuroimmunology. 117: 156-65. PMID 11431016 DOI: 10.1016/S0165-5728(01)00322-8  0.443
1998 Imitola J, Chandraker A, Comabella M, Snyder E, Sayegh M, Khoury S. Neural progenitors expression of B7-1 and B7-2 costimulatory molecules Journal of Neuroimmunology. 90: 16. DOI: 10.1016/S0165-5728(98)91276-0  0.502
Show low-probability matches.